Patrick J Bastian

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi Insignificant prostate cancer and active surveillance: from definition to clinical implications
    Patrick J Bastian
    Urologische Klinik und Poliklinik, Universitätsklinikun der Universität München Grosshadern, Ludwig Maximilians Universitat, Munich, Germany
    Eur Urol 55:1321-30. 2009
  2. ncbi Single-stage dorsal inlay for reconstruction of recurrent peno-glandular stenosis
    Patrick J Bastian
    Urologische Klinik und Poliklinik, Klinikun der Universität München Campus Großhadern, Ludwig Maximilians Universitat, Marchioninistr 15, 81377 Munich, Germany
    World J Urol 30:715-21. 2012
  3. ncbi Alterations of global histone H4K20 methylation during prostate carcinogenesis
    Turang E Behbahani
    Klinik und Poliklinik für Urologie und Kinderurologie, Universitatsklinikum Bonn, Bonn, Germany
    BMC Urol 12:5. 2012
  4. ncbi High-risk prostate cancer: from definition to contemporary management
    Patrick J Bastian
    Department of Urology, Klinikum der Universität München Campus Großhadern, Ludwig Maximilians Universitat, Munich, Germany
    Eur Urol 61:1096-106. 2012
  5. ncbi [CpG island hypermethylation of the DNA. Perspectives of a molecular biomarker for prostate cancer]
    P J Bastian
    Urologische Klinik und Poliklinik, Klinikum der Universitat Munchen Grosshadern, Ludwig Maximilians Universitat Munchen, Munchen, Deutschland
    Urologe A 47:1205-7. 2008
  6. ncbi [Prostatic inflammation and prostate cancer]
    P J Bastian
    Urologische Klinik und Poliklinik, Klinikum der Universität München Campus Grosshadern, Ludwig Maximilians Universitat Munchen, Marchioninistrasse 15, 81377, Munchen, Deutschland
    Urologe A 49:636-8. 2010
  7. ncbi [Results of the evaluation of 85,337 urinary stone analyses]
    P J Bastian
    Urologische Klinik und Poliklinik, Universitätsklinikum Grosshadern, Ludwig Maximilians Universiät München
    Aktuelle Urol 39:298-304. 2008
  8. ncbi Complications of the AdVance transobturator male sling in the treatment of male stress urinary incontinence
    Ricarda M Bauer
    Department of Urology, Ludwig Maximilian University, Munich, Germany
    Urology 75:1494-8. 2010
  9. ncbi External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder
    Philipp Nuhn
    Department of Urology, Ludwig Maximilians Universitat, Munich, Germany
    Eur Urol 61:58-64. 2012
  10. ncbi Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder
    Matthias May
    Department of Urology, St Elisabeth Klinikum Straubing, Straubing, Germany
    Scand J Urol Nephrol 45:251-7. 2011

Collaborators

Detail Information

Publications29

  1. ncbi Insignificant prostate cancer and active surveillance: from definition to clinical implications
    Patrick J Bastian
    Urologische Klinik und Poliklinik, Universitätsklinikun der Universität München Grosshadern, Ludwig Maximilians Universitat, Munich, Germany
    Eur Urol 55:1321-30. 2009
    ..It remains unclear whether all patients diagnosed with prostate cancer warrant radical treatment or may benefit from delayed intervention following active surveillance...
  2. ncbi Single-stage dorsal inlay for reconstruction of recurrent peno-glandular stenosis
    Patrick J Bastian
    Urologische Klinik und Poliklinik, Klinikun der Universität München Campus Großhadern, Ludwig Maximilians Universitat, Marchioninistr 15, 81377 Munich, Germany
    World J Urol 30:715-21. 2012
    ..Urethral glanular reconstruction included a deep dorsal incision followed by complete scar excision to create a deep groove presenting well-vascularized recipient bed ensuring appropriate graft healing...
  3. ncbi Alterations of global histone H4K20 methylation during prostate carcinogenesis
    Turang E Behbahani
    Klinik und Poliklinik für Urologie und Kinderurologie, Universitatsklinikum Bonn, Bonn, Germany
    BMC Urol 12:5. 2012
    ..Our study was designed to assess global methylation levels of histone 4 lysine 20 (H4K20me1-3) at different stages of prostate cancer (PCA) carcinogenesis...
  4. ncbi High-risk prostate cancer: from definition to contemporary management
    Patrick J Bastian
    Department of Urology, Klinikum der Universität München Campus Großhadern, Ludwig Maximilians Universitat, Munich, Germany
    Eur Urol 61:1096-106. 2012
    ..It is clinically important to identify patients with high-risk PCa early on because they stand to benefit the most from curative therapy. Because of recent advances in PCa management, a multimodal approach may be advantageous...
  5. ncbi [CpG island hypermethylation of the DNA. Perspectives of a molecular biomarker for prostate cancer]
    P J Bastian
    Urologische Klinik und Poliklinik, Klinikum der Universitat Munchen Grosshadern, Ludwig Maximilians Universitat Munchen, Munchen, Deutschland
    Urologe A 47:1205-7. 2008
    ..Furthermore using tests in cancer tissue and serum samples, one can draw prognostic conclusions and predict biochemical failure following radical prostatectomy with curative intent...
  6. ncbi [Prostatic inflammation and prostate cancer]
    P J Bastian
    Urologische Klinik und Poliklinik, Klinikum der Universität München Campus Grosshadern, Ludwig Maximilians Universitat Munchen, Marchioninistrasse 15, 81377, Munchen, Deutschland
    Urologe A 49:636-8. 2010
    ..The aim of this paper is to review the epidemiological, moprphological, molecular and clinical aspects of prostattic inflammation and prostate cancer...
  7. ncbi [Results of the evaluation of 85,337 urinary stone analyses]
    P J Bastian
    Urologische Klinik und Poliklinik, Universitätsklinikum Grosshadern, Ludwig Maximilians Universiät München
    Aktuelle Urol 39:298-304. 2008
    ..The frequency of occurrence of whewellite was 75.77% and of wheddellite 46.41%. 34.25% of all calculi were monomineralic and 55.3% were bimineralic...
  8. ncbi Complications of the AdVance transobturator male sling in the treatment of male stress urinary incontinence
    Ricarda M Bauer
    Department of Urology, Ludwig Maximilian University, Munich, Germany
    Urology 75:1494-8. 2010
    ..To evaluate prospectively the complication rate of the retrourethral transobturator sling (AdVance sling) for the functional treatment of male stress urinary incontinence (SUI)...
  9. ncbi External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder
    Philipp Nuhn
    Department of Urology, Ludwig Maximilians Universitat, Munich, Germany
    Eur Urol 61:58-64. 2012
    ..The Bladder Cancer Research Consortium (BCRC) created nomograms to predict all-cause mortality (ACM), cancer-specific mortality (CSM), and recurrence after radical cystectomy (RC) for urothelial carcinoma of the bladder (UCB)...
  10. ncbi Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder
    Matthias May
    Department of Urology, St Elisabeth Klinikum Straubing, Straubing, Germany
    Scand J Urol Nephrol 45:251-7. 2011
    ..This study aimed to evaluate the frequency and prognosis of upstaging in patients undergoing RC due to UCB...
  11. ncbi Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery
    Philipp Nuhn
    Ludwig Maximilians Universitat Munchen, Munich, Germany
    Urol Int 87:42-8. 2011
    ..The aim of this study was to externally validate the prognostic value of concomitant urothelial carcinoma in situ (CIS) in radical cystectomy (RC) specimens using a large international cohort of bladder cancer patients...
  12. ncbi Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder
    Matthias May
    Department of Urology, St Elisabeth Klinikum, Straubing LMU München, Munchen, Germany
    BJU Int 108:E278-83. 2011
    ..To evaluate the characteristics and long-term outcome of patients with pT0 stage after radical cystectomy (RC) for urothelial carcinoma of the urinary bladder (UCB)...
  13. ncbi Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy
    Matthias May
    Department of Urology, St Elisabeth Klinikum Straubing, Straubing, Germany
    Ann Surg Oncol 18:2018-25. 2011
    ....
  14. ncbi Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer
    Michael Seitz
    Department of Urology, Hospital of the University of Munich Campus Grosshadern, Munich, Germany
    Urol Oncol 29:295-301. 2011
    ..In order to determine the ability of contrast-enhanced transrectal ultrasound (CE-TRUS) to identify CaP, we investigated patients scheduled for radical prostatectomy for CaP and radical cystoprostatectomy for bladder cancer...
  15. ncbi Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial
    Christian Bolenz
    Department of Urology, Mannheim Medical Centre, University of Heidelberg, Germany
    BJU Int 106:493-9. 2010
    ..To validate the association of lymphovascular invasion (LVI) with disease recurrence and cancer-specific survival (CSS) in a multicentre cohort of patients treated with radical cystectomy (RC) for urothelial bladder cancer (UBC)...
  16. ncbi Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series
    Derya Tilki
    Department of Urology, Ludwig Maximilians University Munich, Campus Grosshadern, Marchioninistr 15, 81377, Munich, Germany
    World J Urol 28:445-50. 2010
    ..To report on our recent experience with peri- and postoperative morbidity of radical cystectomy in patients 75 years and older compared to younger patients...
  17. ncbi Volar onlay urethroplasty for reconstruction of female urethra in recurrent stricture disease
    Christian Gozzi
    Department of Urology, Klinikum Grosshadern, Ludwig Maximilians University of Munich, Germany
    BJU Int 107:1964-6. 2011
    ..However, there is no consensus regarding the best way to reconstruct the female urethra in the case of stricture disease...
  18. ncbi External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder
    Matthias May
    Department of Urology, St Elisabeth Klinikum, Straubing, Germany
    J Urol 187:1210-4. 2012
    ..We present what is to our knowledge the first external validation of this risk model...
  19. ncbi Prospective evaluation of the functional sling suspension for male postprostatectomy stress urinary incontinence: results after 1 year
    Ricarda M Bauer
    Urological Department, Ludwig Maximilian University, Munich, Germany
    Eur Urol 56:928-33. 2009
    ..In recent years, various minimally invasive sling systems have been investigated as treatment options for such incontinence...
  20. ncbi Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder
    Wolfgang Otto
    Department of Urology, Caritas St Josef Medical Centre, University of Regensburg, Landshuterstrasse 65, Regensburg, Germany
    Gend Med 9:481-9. 2012
    ..Although overall incidence is higher in men, cancer-specific survival (CSS) has been suggested to be lower in women. Although the former effect is attributed to greater exposure to carcinogens in men, the latter has not been elucidated...
  21. ncbi Postprostatectomy incontinence: all about diagnosis and management
    Ricarda M Bauer
    Urologische Klinik und Poliklinik, Ludwig Maximilians Universitat Munchen, Klinikum Grosshadern, Munich, Germany
    Eur Urol 55:322-33. 2009
    ..We provide an overview of the current diagnosis and treatment of postprostatectomy stress incontinence...
  22. ncbi Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma
    Hans Martin Fritsche
    Department of Urology, Caritas St Josef Medical Centre, University of Regensburg, Germany
    Eur Urol 63:739-44. 2013
    ..Perinodal lymphovascular invasion (pnLVI) has not yet been defined...
  23. ncbi Functional magnetic resonance imaging in prostate cancer
    Michael Seitz
    Department of Urology, University of Munich Grosshadern Campus, Munich, Germany
    Eur Urol 55:801-14. 2009
    ....
  24. ncbi Predicting individual outcomes after radical cystectomy: an external validation of current nomograms
    Dirk Zaak
    Department of Urology, Ludwig Maximilians Universitat Munchen, Munich, Germany
    BJU Int 106:342-8. 2010
    ....
  25. ncbi Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer
    Jutta Engel
    Munich Cancer Registry of the Munich Cancer Center, Department of Medical Informatics, Biometry and Epidemiology, Ludwig Maximilians University, Munich, Germany
    Eur Urol 57:754-61. 2010
    ..Positive lymph node (LN) status is considered a systemic disease state. In prostate cancer, LN-positive diagnosis during pelvic LN dissection (PLND) potentially leads to the abandonment of radical prostatectomy (RP)...
  26. ncbi Novel options for the treatment of castration-resistant prostate cancer
    Carsten H Ohlmann
    Department of Urology, Saarland University, Kirrbergerstrasse 1, Homburg Saar, Germany
    World J Urol 30:495-503. 2012
    ..Here, we review the most recent advances in the treatment of CRPC and highlight the most promising new agents currently being investigated in clinical trials...
  27. ncbi Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients
    Derya Tilki
    Klinikum Grosshadern, Ludwig Maximilians Universitat Munchen, Munich, Germany
    J Urol 183:87-93. 2010
    ..We describe cancer specific outcomes in patients with pT4 bladder urothelial carcinoma at radical cystectomy in a large international cohort...
  28. ncbi Cell-free circulating DNA: Diagnostic value in patients with renal cell cancer
    Stefan Hauser
    Department of Urology, University of Bonn, Sigmund Freud Str 25, 53105 Bonn, Germany
    Anticancer Res 30:2785-9. 2010
    ..To analyse the diagnostic and prognostic value of cell-free DNA in patients with renal cell carcinoma (RCC)...
  29. ncbi Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma
    Christian Gratzke
    Department of Urology, Ludwig Maximilians University Munich, Germany
    BJU Int 104:470-5. 2009
    ....